Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of allogeneic mesenchymal precursor cells with corrective heart surgery in children under the age of 5 with hypoplastic left heart syndrome (HLHS)

X
Trial Profile

A study of allogeneic mesenchymal precursor cells with corrective heart surgery in children under the age of 5 with hypoplastic left heart syndrome (HLHS)

Status: Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rexlemestrocel-L (Primary)
  • Indications Hypoplastic left heart syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Apr 2017 New trial record
    • 03 Apr 2017 According to a Mesoblast media release, the United States Food and Drug Administration (FDA) has cleared the commencement of this trial. This trial is sponsored and funded by the Boston Childrens Hospital with support from Bulens and Capozzi Foundation and the Ethan Lindberg Foundation. Dr. Sitaram Emani is Principal Investigator of this study.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top